GlobalView

Talley, Nicholas J.

Statistics
Title Hits Visitors Downloads
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics 88 81 0
Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review 31 29 0
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study 44 42 0
Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis 274 258 0
What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome?: are current IBS symptom thresholds clinically meaningful? 38 36 0
Irritable bowel syndrome: rational therapy 49 49 0
Esophageal and gastric motor function 46 42 0
Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis 213 193 0
The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene–environment interactions in Irritable Bowel Syndrome (IBS) 49 42 0
Eosinophilic gastroenteritis 38 37 0
Prospective diary evaluation of unexplained abdominal pain and bowel dysfunction: a population-based colonoscopy study 118 111 0
Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia 77 71 0
Increased incidence of eosinophilic esophagitis in children and adults with celiac disease 51 48 0
Sexual, physical, verbal/emotional abuse and unexplained chest pain 59 49 0
Consensus statements for management of Barrett's Dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process 117 98 0
Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy 63 62 0
Challenges and lessons learned in conducting comparative-effectiveness trials 36 34 0
Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. 28 27 0
Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? 42 42 0
Gambling with gastroesophageal reflux disease: should we worry about the QALY? (editorial) 38 35 0
5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis 118 104 0
Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole - results from the STARS II study 67 60 0
Management of noncardiac chest pain in women 45 36 0
Overlap: irritable bowel syndrome, inflammatory bowel disease, and diverticular disease 78 71 0
Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population 81 75 0
Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in Olmsted County, Minnesota 21 20 0
Factor analysis identifies subgroups of constipation 71 63 0
Minimum clinically important difference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia 63 59 0
Meta-analysis: the epidemiology of noncardiac chest pain in the community 36 35 0
Spectrum of gastroparesis in children 70 58 0
Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis 307 280 0
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis 88 85 0
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture 113 96 0
The role of eosinophils and mast cells in intestinal functional disease 58 52 0
Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study 68 57 0
An evidence-based systematic review on medical therapies for inflammatory bowel disease 675 553 0
Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study 61 59 0
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis 99 92 0
Novel biomarker panel for the irritable bowel syndrome: a diagnostic blood test is promising 49 47 0
Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population 42 41 0
Longitudinal direct medical costs associated with constipation in women 115 103 0
Fecal incontinence: mechanisms and management 30 29 0
An update on irritable bowel syndrome: from diagnosis to emerging therapies 62 61 0
Factors associated with persistent and nonpersistent chronic constipation, over 20 years 80 74 0
Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis 55 54 0
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis 89 82 0
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis 285 262 0
Pathways connecting cognitive behavioral therapy and change in bowel symptoms of IBS 73 60 0
Repository Search URL

Talley, Nicholas J.

Formatted Bibliography URL

Talley, Nicholas J.

Bibliography Markup

To include a live feed of this author's bibliography on a static Web page (e.g., a personal home page), add the following HTML code to the body of your HTML.